Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Eckert | M | 69 | 21 years | |
David Reese | M | 61 | 19 years | |
Matthew Busch | M | 50 | 20 years | |
Derek Miller | M | - | 21 years | |
Mike Zahigian | M | - | 23 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David W. Beier | M | 75 | 10 years | |
Michael Kelly | M | 67 | 14 years | |
Paul Eisenberg | M | - | 14 years | |
Kathryn Falberg | F | 63 | 6 years | |
James Parsons | M | 58 |
Trillium Therapeutics, Inc. /Old/
Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Trillium Therapeutics Inc. (TTI), is a biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune-mediated disorders. The Company's therapeutic approaches are aimed at restoring balance to the immune system in conditions associated with aberrant or harmful immune responses, such as autoimmune disease, inflammatory disorders, and cancer. TTI's objective is to create a broad and innovative pipeline of proprietary biologic product opportunities, as part of its overall strategy of building and solidifying its reputation as a premier R & D company. The company's business model is to identify therapeutic candidates that have shown promise in animal models and to rapidly advance these into clinical testing. TTI is concentrating its efforts on preclinical and early clinical drug development, with the primary objective of demonstrating safety and proof-of-principle in man. The company has chosen to establish development partnerships for some of its projects at a preclinical stage, and anticipates advancing several others into clinical development on its own. TTI has five scientific programs at various stages of preclinical testing. Two of its programs focus on the immunoregulatory protein CD200 and its receptor, a third targets the activating Fc receptor Fc RIIa (CD32a) and the final two involve the use of a growth factor in the prevention of necrotizing enterocolitis and the treatment of interstitial cystitis. | 11 years |
James Daly | M | 62 | 9 years | |
Erin Lavelle | F | 46 | 15 years | |
John Smither | M | 71 | 6 years | |
Jin Long Chen | M | 61 | 4 years | |
Cynthia Flowers | F | 64 | 5 years | |
William P. Sheridan | M | 69 | 5 years | |
William Ashton | M | 73 | 16 years | |
Willard Dere | M | 70 | 11 years | |
Leonard Schaeffer | M | 78 | 9 years | |
Preston Klassen | M | 55 | 7 years | |
Frank J. Biondi | M | 79 | 15 years | |
John Moriarty | M | 56 | 6 years | |
Diana McKenzie | F | 59 | 12 years | |
Thomas Zindrick | M | 65 | 8 years | |
Sean E. Harper | M | 61 | 16 years | |
Gregory L. Tewalt | M | - | - | |
Michael Severino | M | 58 | 10 years | |
Cynthia Patton | F | 62 | 15 years | |
Vasant Prakash Gandhi | M | - | 5 years | |
Sean B. W. Martin | M | 61 | - | |
Susan Lundeen Smuck | F | 57 | 12 years | |
Craig Shepherd | M | - | 7 years | |
Brian M. McNamee | M | 67 | - | |
Anna Richo | F | 63 | 9 years | |
Timothy Martin | M | 55 | 3 years | |
Patricia Cary Sueltz | F | 71 | 2 years | |
J. Reason | M | 83 | 12 years | |
Frank Herringer | M | 81 | 15 years | |
Rachel Lenington | F | 51 | 10 years | |
George Morrow | M | 72 | 10 years | |
David J. Scott | M | 71 | - | |
Dominique Monnet | M | 65 | 11 years | |
Richard Alexander | M | - |
Brandeis University
| 4 years |
Margrit Schwarz | M | 60 | 7 years | |
Windsor N. Hall | M | - |
Brandeis University
| 4 years |
Larry H. Levy | M | - |
Brandeis University
| 4 years |
Roland Wandeler | M | 51 | - | |
Wendee Wolfson | F | - |
Brandeis University
| 4 years |
Paul Romness | M | 57 | 3 years | |
Feng Ye | M | 57 | 12 years | |
David Essayan | M | - | 4 years | |
Jörn Drappa | M | 60 | 3 years | |
Laura Hamill | F | 60 | 18 years | |
Ann Miller | M | 66 | 5 years | |
Krishnan Mahesh /davita/ | - | - | 5 years | |
Joseph Leveque | M | 63 | 2 years | |
Kirsten Detrick | F | 59 | 9 years | |
Brian Sweeney | M | 59 | 15 years | |
Andrew Partridge | M | 55 | 10 years | |
Joanne Viney | M | 58 | 9 years | |
Luis Borges | M | 62 | 12 years | |
Reshma Kewalramani | M | 51 | 13 years | |
Charalampos A. Makkas | M | 72 |
Brandeis University
| 4 years |
Michael A. Grabow | M | - | 13 years | |
David Hovland | M | - | 8 years | |
Sunita Zalani | M | - | 8 years | |
Richard M. Blau | M | - |
Brandeis University
| 4 years |
Stuart Arbuckle | M | 58 | 8 years | |
David Parkinson | M | 73 | 3 years | |
Steve Lazarus | M | - | 17 years | |
Barry Kaplan | M | - |
Brandeis University
| 4 years |
Joseph P. Miletich | M | - | 12 years | |
Jacqueline Sonnabend | F | 69 |
Brandeis University
| 4 years |
John F. Weidenbruch | M | 63 | 10 years | |
Helen Torley | M | 61 | 8 years | |
Bill Wittenberg | M | - |
Brandeis University
| 4 years |
Richard Nanula | M | 63 | 6 years | |
Richard Seth Rosen | M | 66 |
Brandeis University
| 4 years |
Christie Hefner | F | 71 |
Brandeis University
| 4 years |
Matthew Moyle | M | 63 | 6 years | |
Candace E. Browning-Platt | F | - |
Brandeis University
| 4 years |
William J. Kane | M | - |
Brandeis University
| 4 years |
Paul J. Carter | M | - | 1 years | |
William D. Freedman | M | - |
Brandeis University
| 4 years |
Sandra Milligan | M | 60 | 10 years | |
Daniel J. Jick | M | - |
Brandeis University
| 4 years |
Eric Weinstein | M | 71 |
Brandeis University
| 4 years |
Robin D. Campbell | M | 69 | 13 years | |
Andrew B. Hahn | M | - |
Brandeis University
| 3 years |
Michael N. Kahn | M | - |
Brandeis University
| 4 years |
Dan Jick | M | - |
Brandeis University
| 4 years |
Jerome Kemp | M | - |
Brandeis University
| 4 years |
Gilbert M. Rishton | M | - | 9 years | |
Gary Palmer | M | - | 5 years | |
Daniel I. Schlessinger | M | - |
Brandeis University
| 4 years |
Andy R. Stern | M | - |
Brandeis University
| 4 years |
Gordon Ng | M | - | 9 years | |
Stanley Roth | M | - |
Brandeis University
| 4 years |
Aron M. Knickerbocker | M | 54 | 4 years | |
Mike Nanfito | M | - | 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 99 | 99.00% |
Canada | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael J. Gresser
- Personal Network